Padovan-Merhar OM, Raman P, Ostrovnaya I, Kalletla K, Rubnitz KR, Sanford EM, et al. Enrichment of targetable mutations in the relapsed neuroblastoma genome. Plos Genet. 2016;12(12):e1006501.
Article
PubMed
PubMed Central
Google Scholar
Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369(9579):2106–20.
Article
CAS
PubMed
Google Scholar
Matthay KK, Maris JM, Schleiermacher G, Nakagawara A, Mackall CL, Diller L, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078.
Article
PubMed
Google Scholar
Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202–11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Perri P, Ponzoni M, Corrias MV, Ceccherini I, Candiani S, Bachetti T. A focus on regulatory networks linking micrornas, transcription factors and target genes in neuroblastoma. Cancers (Basel). 2021;13(21):5528.
Longo L, Tonini GP, Ceccherini I, Perri P. Oligogenic inheritance in neuroblastoma. Cancer Lett. 2005;228(1–2):65–9.
Article
CAS
PubMed
Google Scholar
Schwab M. Amplification of the MYCN oncogene and deletion of putative tumour suppressor gene in human neuroblastomas. Brain Pathol. 1990;1(1):41–6.
Article
CAS
PubMed
Google Scholar
Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F, et al. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature. 1983;305(5931):245–8.
Article
CAS
PubMed
Google Scholar
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science. 1984;224(4653):1121–4.
Article
CAS
PubMed
Google Scholar
Chen Y, Takita J, Choi YL, Kato M, Ohira M, Sanada M, et al. Oncogenic mutations of ALK kinase in neuroblastoma. Nature. 2008;455(7215):971–4.
Article
CAS
PubMed
Google Scholar
George RE, Sanda T, Hanna M, Frohling S, Luther W 2nd, Zhang J, et al. Activating mutations in ALK provide a therapeutic target in neuroblastoma. Nature. 2008;455(7215):975–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Janoueix-Lerosey I, Lequin D, Brugieres L, Ribeiro A, de Pontual L, Combaret V, et al. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma. Nature. 2008;455(7215):967–70.
Article
CAS
PubMed
Google Scholar
Mosse YP, Laudenslager M, Longo L, Cole KA, Wood A, Attiyeh EF, et al. Identification of ALK as a major familial neuroblastoma predisposition gene. Nature. 2008;455(7215):930–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bourdeaut F, Trochet D, Janoueix-Lerosey I, Ribeiro A, Deville A, Coz C, et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Cancer Lett. 2005;228(1–2):51–8.
Article
CAS
PubMed
Google Scholar
Trochet D, Bourdeaut F, Janoueix-Lerosey I, Deville A, de Pontual L, Schleiermacher G, et al. Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma. Am J Hum Genet. 2004;74(4):761–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
van Limpt V, Chan A, Schramm A, Eggert A, Versteeg R. Phox2B mutations and the Delta-Notch pathway in neuroblastoma. Cancer Lett. 2005;228(1–2):59–63.
Article
PubMed
Google Scholar
van Limpt V, Schramm A, van Lakeman A, Sluis P, Chan A, van Noesel M, et al. The Phox2B homeobox gene is mutated in sporadic neuroblastomas. Oncogene. 2004;23(57):9280–8.
Article
PubMed
Google Scholar
Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, et al. The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013;45(3):279–84.
Article
CAS
PubMed
PubMed Central
Google Scholar
Valentijn LJ, Koster J, Zwijnenburg DA, Hasselt NE, van Sluis P, Volckmann R, et al. TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors. Nat Genet. 2015;47(12):1411–4.
Article
CAS
PubMed
Google Scholar
Ackermann S, Cartolano M, Hero B, Welte A, Kahlert Y, Roderwieser A, et al. A mechanistic classification of clinical phenotypes in neuroblastoma. Science. 2018;362(6419):1165–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bordow SB, Norris MD, Haber PS, Marshall GM, Haber M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol. 1998;16(10):3286–94.
Article
CAS
PubMed
Google Scholar
Dzieran J, Rodriguez Garcia A, Westermark UK, Henley AB, Eyre Sanchez E, Trager C, et al. MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling. Proc Natl Acad Sci U S A. 2018;115(6):E1229–E38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zeid R, Lawlor MA, Poon E, Reyes JM, Fulciniti M, Lopez MA, et al. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat Genet. 2018;50(4):515-23.
Westermann F, Muth D, Benner A, Bauer T, Henrich KO, Oberthuer A, et al. Distinct transcriptional MYCN/c-MYC activities are associated with spontaneous regression or malignant progression in neuroblastomas. Genome Biol. 2008;9(10):R150.
Article
PubMed
PubMed Central
Google Scholar
Longo L, Borghini S, Schena F, Parodi S, Albino D, Bachetti T, et al. PHOX2A and PHOX2B genes are highly co-expressed in human neuroblastoma. Int J Oncol. 2008;33(5):985–91.
CAS
PubMed
Google Scholar
Raabe EH, Laudenslager M, Winter C, Wasserman N, Cole K, LaQuaglia M, et al. Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene. 2008;27(4):469–76.
Article
CAS
PubMed
Google Scholar
Molenaar JJ, Domingo-Fernandez R, Ebus ME, Lindner S, Koster J, Drabek K, et al. LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet. 2012;44(11):1199–206.
Article
CAS
PubMed
Google Scholar
Hennchen M, Stubbusch J, Abarchan-El Makhfi I, Kramer M, Deller T, Pierre-Eugene C, et al. Lin28B and Let-7 in the control of sympathetic neurogenesis and neuroblastoma development. J Neurosci. 2015;35(50):16531–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Westermark UK, Wilhelm M, Frenzel A, Henriksson MA. The MYCN oncogene and differentiation in neuroblastoma. Semin Cancer Biol. 2011;21(4):256–66.
Article
CAS
PubMed
Google Scholar
Higashi M, Sakai K, Fumino S, Aoi S, Furukawa T, Tajiri T. The roles played by the MYCN, Trk, and ALK genes in neuroblastoma and neural development. Surg Today. 2019;49(9):721–7.
Article
CAS
PubMed
Google Scholar
Rohrer H. Transcriptional control of differentiation and neurogenesis in autonomic ganglia. Eur J Neurosci. 2011;34(10):1563–73.
Article
PubMed
Google Scholar
van Groningen T, Koster J, Valentijn LJ, Zwijnenburg DA, Akogul N, Hasselt NE, et al. Neuroblastoma is composed of two super-enhancer-associated differentiation states. Nat Genet. 2017;49(8):1261–6.
Article
PubMed
Google Scholar
van Groningen T, Akogul N, Westerhout EM, Chan A, Hasselt NE, Zwijnenburg DA, et al. A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma. Nat Commun. 2019;10(1):1530.
Article
PubMed
PubMed Central
Google Scholar
Tang W, Bronner ME. Neural crest lineage analysis: from past to future trajectory. Development. 2020;147(20):dev193193.
Olsen RR, Otero JH, Garcia-Lopez J, Wallace K, Finkelstein D, Rehg JE, et al. MYCN induces neuroblastoma in primary neural crest cells. Oncogene. 2017;36(35):5075–82.
Article
CAS
PubMed
PubMed Central
Google Scholar
His W. Untersuchungen über die erste Anlage des Wirbelthierleibes: die erste Entwickelung des Hühnchens im Ei. Vogel. 1868.
Rasmuson A, Segerstrom L, Nethander M, Finnman J, Elfman LH, Javanmardi N, et al. Tumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma. Plos One. 2012;7(12):e51297.
Article
CAS
PubMed
PubMed Central
Google Scholar
Betters E, Liu Y, Kjaeldgaard A, Sundstrom E, Garcia-Castro MI. Analysis of early human neural crest development. Dev Biol. 2010;344(2):578–92.
Article
CAS
PubMed
PubMed Central
Google Scholar
O'Rahilly R, Muller F. The development of the neural crest in the human. J Anat. 2007;211(3):335–51.
Article
PubMed
PubMed Central
Google Scholar
Bedoya-Reina OC, Schlisio S. Chromaffin cells with Sympathoblast signature: too similar to keep apart? Cancer Cell. 2021;39(2):134–5.
Article
CAS
PubMed
Google Scholar
Chan WH, Gonsalvez DG, Young HM, Southard-Smith EM, Cane KN, Anderson CR. Differences in CART expression and cell cycle behavior discriminate sympathetic neuroblast from chromaffin cell lineages in mouse sympathoadrenal cells. Dev Neurobiol. 2016;76(2):137–49.
Article
CAS
PubMed
Google Scholar
Furlan A, Dyachuk V, Kastriti ME, Calvo-Enrique L, Abdo H, Hadjab S, et al. Multipotent peripheral glial cells generate neuroendocrine cells of the adrenal medulla. Science. 2017;357(6346):eaal3753.
Dong R, Yang R, Zhan Y, Lai HD, Ye CJ, Yao XY, et al. Single-cell characterization of malignant phenotypes and developmental trajectories of adrenal neuroblastoma. Cancer Cell. 2020;38(5):716–33 e6.
Article
CAS
PubMed
Google Scholar
Jansky S, Sharma AK, Korber V, Quintero A, Toprak UH, Wecht EM, et al. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma. Nat Genet. 2021;53(5):683–93.
Article
CAS
PubMed
Google Scholar
Kameneva P, Artemov AV, Kastriti ME, Faure L, Olsen TK, Otte J, et al. Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin. Nat Genet. 2021;53(5):694–706.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kastriti ME, Kameneva P, Kamenev D, Dyachuk V, Furlan A, Hampl M, et al. Schwann cell precursors generate the majority of chromaffin cells in Zuckerkandl organ and some sympathetic neurons in Paraganglia. Front Mol Neurosci. 2019;12:6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kildisiute G, Young MD, Behjati S. Pitfalls of applying mouse markers to human adrenal medullary cells. Cancer Cell. 2021;39(2):132–3.
Article
CAS
PubMed
Google Scholar
Yang R, Luo W, Zhan Y, Li K, Wang J, Dong R. Response to Kildsiute et al. and Bedoya-Reina and Schlisio. Cancer Cell. 2021;39(2):136–7.
Article
CAS
PubMed
Google Scholar
Simoes-Costa M, Bronner ME. Establishing neural crest identity: a gene regulatory recipe. Development. 2015;142(2):242–57.
Article
CAS
PubMed
PubMed Central
Google Scholar
Varley JE, Maxwell GD. BMP-2 and BMP-4, but not BMP-6, increase the number of adrenergic cells which develop in quail trunk neural crest cultures. Exp Neurol. 1996;140(1):84–94.
Article
CAS
PubMed
Google Scholar
Varley JE, McPherson CE, Zou H, Niswander L, Maxwell GD. Expression of a constitutively active type I BMP receptor using a retroviral vector promotes the development of adrenergic cells in neural crest cultures. Dev Biol. 1998;196(1):107–18.
Article
CAS
PubMed
Google Scholar
Streit A, Berliner AJ, Papanayotou C, Sirulnik A, Stern CD. Initiation of neural induction by FGF signalling before gastrulation. Nature. 2000;406(6791):74–8.
Article
CAS
PubMed
Google Scholar
Garcia-Castro MI, Marcelle C, Bronner-Fraser M. Ectodermal Wnt function as a neural crest inducer. Science. 2002;297(5582):848–51.
Article
CAS
PubMed
Google Scholar
Saito D, Takase Y, Murai H, Takahashi Y. The dorsal aorta initiates a molecular cascade that instructs sympatho-adrenal specification. Science. 2012;336(6088):1578–81.
Article
CAS
PubMed
Google Scholar
Kerosuo L, Neppala P, Hsin J, Mohlin S, Vieceli FM, Torok Z, et al. Enhanced expression of MycN/CIP2A drives neural crest toward a neural stem cell-like fate: implications for priming of neuroblastoma. Proc Natl Acad Sci U S A. 2018;115(31):E7351–E60.
Article
CAS
PubMed
PubMed Central
Google Scholar
Soldatov R, Kaucka M, Kastriti ME, Petersen J, Chontorotzea T, Englmaier L, et al. Spatiotemporal structure of cell fate decisions in murine neural crest. Science. 2019;364(6444):eaas9536.
Saito D, Takahashi Y. Sympatho-adrenal morphogenesis regulated by the dorsal aorta. Mech Dev. 2015;138(Pt 1):2–7.
Article
CAS
PubMed
Google Scholar
Pattyn A, Morin X, Cremer H, Goridis C, Brunet JF. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature. 1999;399(6734):366–70.
Article
CAS
PubMed
Google Scholar
Kirino K, Nakahata T, Taguchi T, Saito MK. Efficient derivation of sympathetic neurons from human pluripotent stem cells with a defined condition. Sci Rep. 2018;8(1):12865.
Article
PubMed
PubMed Central
Google Scholar
Hirsch MR, Tiveron MC, Guillemot F, Brunet JF, Goridis C. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development. 1998;125(4):599–608.
Article
CAS
PubMed
Google Scholar
Vincentz JW, VanDusen NJ, Fleming AB, Rubart M, Firulli BA, Howard MJ, et al. A Phox2- and Hand2-dependent Hand1 cis-regulatory element reveals a unique gene dosage requirement for Hand2 during sympathetic neurogenesis. J Neurosci. 2012;32(6):2110–20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wakamatsu Y, Watanabe Y, Nakamura H, Kondoh H. Regulation of the neural crest cell fate by N-myc: promotion of ventral migration and neuronal differentiation. Development. 1997;124(10):1953–62.
Article
CAS
PubMed
Google Scholar
Huang M, Weiss WA. Neuroblastoma and MYCN. Cold Spring Harb Perspect Med. 2013;3(10):a014415.
Article
PubMed
PubMed Central
Google Scholar
Knoepfler PS, Cheng PF, Eisenman RN. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002;16(20):2699–712.
Article
CAS
PubMed
PubMed Central
Google Scholar
Alam G, Cui H, Shi H, Yang L, Ding J, Mao L, et al. MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am J Pathol. 2009;175(2):856–66.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim J, Lo L, Dormand E, Anderson DJ. SOX10 maintains multipotency and inhibits neuronal differentiation of neural crest stem cells. Neuron. 2003;38(1):17–31.
Article
CAS
PubMed
Google Scholar
Tsarovina K, Schellenberger J, Schneider C, Rohrer H. Progenitor cell maintenance and neurogenesis in sympathetic ganglia involves Notch signaling. Mol Cell Neurosci. 2008;37(1):20–31.
Article
CAS
PubMed
Google Scholar
Moore R, Alexandre P. delta-notch signaling: the long and the short of a neuron’s influence on progenitor fates. J Dev Biol. 2020;8(2):8.
Izumi H, Kaneko Y. Evidence of asymmetric cell division and centrosome inheritance in human neuroblastoma cells. Proc Natl Acad Sci U S A. 2012;109(44):18048–53.
Article
CAS
PubMed
PubMed Central
Google Scholar
Izumi H, Kaneko Y, Nakagawara A. The role of MYCN in symmetric vs. Asymmetric cell division of human neuroblastoma cells. Front Oncol. 2020;10:570815.
Article
PubMed
PubMed Central
Google Scholar
Furlan A, Adameyko I. Schwann cell precursor: a neural crest cell in disguise? Dev Biol. 2018;444(Suppl 1):S25–35.
Article
CAS
PubMed
Google Scholar
Hanemaaijer ES, Margaritis T, Sanders K, Bos FL, Candelli T, Al-Saati H, et al. Single-cell atlas of developing murine adrenal gland reveals relation of Schwann cell precursor signature to neuroblastoma phenotype. Proc Natl Acad Sci U S A. 2021;118(5):e2022350118.
Aragao-Santiago L, Gomez-Sanchez CE, Mulatero P, Spyroglou A, Reincke M, Williams TA. Mouse models of primary Aldosteronism: from physiology to pathophysiology. Endocrinology. 2017;158(12):4129–38.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bedoya-Reina OC, Li W, Arceo M, Plescher M, Bullova P, Pui H, et al. Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors. Nat Commun. 2021;12(1):5309.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boeva V, Louis-Brennetot C, Peltier A, Durand S, Pierre-Eugene C, Raynal V, et al. Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat Genet. 2017;49(9):1408–13.
Article
CAS
PubMed
Google Scholar
Skrypek N, Goossens S, De Smedt E, Vandamme N, Berx G. Epithelial-to-mesenchymal transition: epigenetic reprogramming driving cellular plasticity. Trends Genet. 2017;33(12):943–59.
Article
CAS
PubMed
Google Scholar
Kildisiute G, Kholosy WM, Young MD, Roberts K, Elmentaite R, van Hooff SR, et al. Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell. Sci Adv. 2021;7(6):eabd3311.
Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, et al. Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature. 2015;526(7575):700–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Haghverdi L, Buettner F, Theis FJ. Diffusion maps for high-dimensional single-cell analysis of differentiation data. Bioinformatics. 2015;31(18):2989–98.
Article
CAS
PubMed
Google Scholar
Zimmerman MW, Liu Y, He S, Durbin AD, Abraham BJ, Easton J, et al. MYC drives a subset of high-risk pediatric neuroblastomas and is activated through mechanisms including enhancer hijacking and focal enhancer amplification. Cancer Discov. 2018;8(3):320–35.
Article
CAS
PubMed
Google Scholar
Helmsauer K, Valieva ME, Ali S, Chamorro Gonzalez R, Schopflin R, Roefzaad C, et al. Enhancer hijacking determines extrachromosomal circular MYCN amplicon architecture in neuroblastoma. Nat Commun. 2020;11(1):5823.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olsen TKO J, Mei S, Kameneva P, Björklund A, Kryukov E, Hou Z, et al. Malignant Schwann cell precursors mediate intratumoral plasticity in human neuroblastoma. bioRxiv. 2020. https://doi.org/10.1101/2020.05.04.077057.
Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the international neuroblastoma pathology committee. Cancer. 1999;86(2):349–63.
Article
CAS
PubMed
Google Scholar
Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, et al. The international neuroblastoma pathology classification (the Shimada system). Cancer. 1999;86(2):364–72.
Article
CAS
PubMed
Google Scholar
Oldridge DA, Truong B, Russ D, DuBois SG, Vaksman Z, Mosse YP, et al. Differences in genomic profiles and outcomes between thoracic and adrenal neuroblastoma. J Natl Cancer Inst. 2019;111(11):1192–201.
Article
PubMed
PubMed Central
Google Scholar
Rohrer H. Linking human sympathoadrenal development and neuroblastoma. Nat Genet. 2021;53(5):593–4.
Article
CAS
PubMed
Google Scholar
Gartlgruber M, Sharma AK, Quintero A, Dreidax D, Jansky S, Park YG, et al. Super enhancers define regulatory subtypes and cell identity in neuroblastoma. Nat Cancer. 2021;2(1):114–+.
Article
CAS
PubMed
Google Scholar
Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, et al. Super-enhancers in the control of cell identity and disease. Cell. 2013;155(4):934–47.
Article
CAS
PubMed
Google Scholar
Hnisz D, Schuijers J, Lin CY, Weintraub AS, Abraham BJ, Lee TI, et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell. 2015;58(2):362–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell. 2013;153(2):307–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973;33(11):2643–52.
CAS
PubMed
Google Scholar
Ciccarone V, Spengler BA, Meyers MB, Biedler JL, Ross RA. Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res. 1989;49(1):219–25.
CAS
PubMed
Google Scholar
Zhang TT, Zhang ZQ, Dong Q, Xiong J, Zhu B. Histone H3K27 acetylation is dispensable for enhancer activity in mouse embryonic stem cells. Genome Biol. 2020;21(1):45.
van Groningen TJB. Intra-tumor heterogeneity and lineage plasticity in neuroblastoma. PhD Thesis [PhD Thesis]. Amsterdam: University of Amsterdam; 2020.
Google Scholar
Zhang W, Landback P, Gschwend AR, Shen B, Long M. New genes drive the evolution of gene interaction networks in the human and mouse genomes. Genome Biol. 2015;16:202.
Article
PubMed
PubMed Central
Google Scholar
Chronis C, Fiziev P, Papp B, Butz S, Bonora G, Sabri S, et al. Cooperative binding of transcription factors orchestrates reprogramming. Cell. 2017;168(3):442–59 e20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ross RA, Spengler BA, Biedler JL. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst. 1983;71(4):741–7.
CAS
PubMed
Google Scholar
Koch U, Lehal R, Radtke F. Stem cells living with a Notch. Development. 2013;140(4):689–704.
Article
CAS
PubMed
Google Scholar
Thirant CPA, Durand S, Kramdi A, Louis-Brennetot C, Pierre-Eugène C, Costa A, et al. Interplay between intrinsic reprogramming potential and microenvironment controls neuroblastoma cell plasticity and identity. bioRxiv. 2021.
Gautier M, Thirant C, Delattre O, Janoueix-Lerosey I. Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT). Cancers (Basel). 2021;13(12).
Westerhout EM, Hamdi M, Stroeken P, Nowakowska NE, Lakeman A, van Arkel J, et al. Mesenchymal type neuroblastoma cells escape ALK inhibitors. Cancer Res. 2021.
Kong X, Pan P, Sun H, Xia H, Wang X, Li Y, et al. Drug discovery targeting anaplastic lymphoma kinase (ALK). J Med Chem. 2019;62(24):10927–54.
Article
CAS
PubMed
Google Scholar
Infarinato NR, Park JH, Krytska K, Ryles HT, Sano R, Szigety KM, et al. The ALK/ROS1 inhibitor PF-06463922 overcomes primary resistance to Crizotinib in ALK-driven neuroblastoma. Cancer Discov. 2016;6(1):96–107.
Article
CAS
PubMed
Google Scholar
Durbin AD, Zimmerman MW, Dharia NV, Abraham BJ, Iniguez AB, Weichert-Leahey N, et al. Selective gene dependencies in MYCN-amplified neuroblastoma include the core transcriptional regulatory circuitry. Nat Genet. 2018;50(9):1240–6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang K, Diskin SJ, Zhang H, Attiyeh EF, Winter C, Hou C, et al. Integrative genomics identifies LMO1 as a neuroblastoma oncogene. Nature. 2011;469(7329):216–20.
Article
CAS
PubMed
Google Scholar
Oldridge DA, Wood AC, Weichert-Leahey N, Crimmins I, Sussman R, Winter C, et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature. 2015;528(7582):418–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang L, Tan TK, Durbin AD, Zimmerman MW, Abraham BJ, Tan SH, et al. ASCL1 is a MYCN- and LMO1-dependent member of the adrenergic neuroblastoma core regulatory circuitry. Nat Commun. 2019;10(1):5622.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sengupta S, George RE. Super-enhancer-driven transcriptional dependencies in Cancer. Trends Cancer. 2017;3(4):269–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghandi M, Huang FW, Jane-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3rd, et al. Next-generation characterization of the Cancer cell line encyclopedia. Nature. 2019;569(7757):503–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cotterman R, Knoepfler PS. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS One. 2009;4(6):e5799.
Article
PubMed
PubMed Central
Google Scholar
Kang JH, Rychahou PG, Ishola TA, Qiao J, Evers BM, Chung DH. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Biochem Biophys Res Commun. 2006;351(1):192–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Henriksen JR, Haug BH, Buechner J, Tomte E, Lokke C, Flaegstad T, et al. Conditional expression of retrovirally delivered anti-MYCN shRNA as an in vitro model system to study neuronal differentiation in MYCN-amplified neuroblastoma. BMC Dev Biol. 2011;11:1.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nara K, Kusafuka T, Yoneda A, Oue T, Sangkhathat S, Fukuzawa M. Silencing of MYCN by RNA interference induces growth inhibition, apoptotic activity and cell differentiation in a neuroblastoma cell line with MYCN amplification. Int J Oncol. 2007;30(5):1189–96.
CAS
PubMed
Google Scholar
Manohar CF, Bray JA, Salwen HR, Madafiglio J, Cheng A, Flemming C, et al. MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma. Oncogene. 2004;23(3):753–62.
Article
CAS
PubMed
Google Scholar
Kohno K, Uchiumi T, Niina I, Wakasugi T, Igarashi T, Momii Y, et al. Transcription factors and drug resistance. Eur J Cancer. 2005;41(16):2577–86.
Article
CAS
PubMed
Google Scholar
van Staalduinen J, Baker D, Ten Dijke P, van Dam H. Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? Oncogene. 2018;37(48):6195–211.
Article
PubMed
Google Scholar